PTC Therapeutics reports results of 2025 annual meeting; all three proposals approved

PTC THERAPEUTICS, INC.

Elected Allan Jacobson (60,386,986 for), David Southwell (59,200,375), Alethia Young (54,894,657) as Class III directors to 2028 term.
Ratified Ernst & Young as independent auditor for FY 2025: 67,259,475 for, 195,233 against, 21,362 abstained.
Approved non-binding advisory vote on executive compensation: 60,479,157 for, 1,979,310 against, 44,711 abstained.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.